Category: Uncategorized

Nov 23 2020

Uncategorized

Global Schizophrenia Market to 2030 – Insights, Epidemiology and Market Forecast – ResearchAndMarkets.com

by Clinical Editor

No Comments

Market Insights, Epidemiology and Market Forecast – 2030″ drug pipelines has been added to ResearchAndMarkets.com’s offering.

Nov 22 2020

Uncategorized

Abhishek Banerjee On Fighting His Own Demons And Battling With Mom’s Schizophrenia

by Clinical Editor

No Comments

Strong, muscular, tall, macho, suave – we wouldn’t blame you if you thought we were describing a man. The image associated with men has always inclined towards the physical aspect...

Nov 22 2020

Uncategorized

Feinstein Institutes Researchers Help Lead $52M Study of Schizophrenia in High-Risk Youth

by Clinical Editor

No Comments

Researchers from The Feinstein Institutes for Medical Research and two other institutions have been awarded a $52 million, five-year grant from the National Institute of Mental Health (NIMH) to lead...

Nov 22 2020

Uncategorized

Year in Review: Schizophrenia

by Clinical Editor

No Comments

In September, the American Psychiatric Association released new recommendations for treatment of schizophrenia– the first update since 2009. Although the guidelines reflect a shift towards shared …

Nov 22 2020

Uncategorized

Improving the Design of Clinical Trials of Drugs to Treat Schizophrenia

by Clinical Editor

No Comments

CDER research has identified ways to streamline schizophrenia drug trials without compromising their sensitivity.

Nov 22 2020

Uncategorized

Long-acting antipsychotic therapy plus cognitive training show promise for schizophrenia

by Clinical Editor

No Comments

Scientists have found that the use of long-acting antipsychotic medication combined with the use of cognitive training in group settings led to improved cognition and increased productivity.

Nov 21 2020

Uncategorized

Feinstein Institutes Researchers Help Lead $52M Study of Schizophrenia in High-Risk Youth

by Clinical Editor

No Comments

Researchers from The Feinstein Institutes for Medical Research and two other institutions have been awarded a $52 million, five-year grant from the National Institute of Mental Health (NIMH) to lead...

Nov 21 2020

Uncategorized

Long-acting antipsychotic therapy plus cognitive training show promise for schizophrenia

by Clinical Editor

No Comments

Scientists have found that the use of long-acting antipsychotic medication combined with the use of cognitive training in group settings led to improved cognition and increased productivity.

Nov 21 2020

Uncategorized

Abhishek Banerjee On Fighting His Own Demons And Battling With Mom’s Schizophrenia

by Clinical Editor

No Comments

Strong, muscular, tall, macho, suave – we wouldn’t blame you if you thought we were describing a man. The image associated with men has always inclined towards the physical aspect...

Nov 21 2020

Uncategorized

Year in Review: Schizophrenia

by Clinical Editor

No Comments

In September, the American Psychiatric Association released new recommendations for treatment of schizophrenia– the first update since 2009. Although the guidelines reflect a shift towards shared …